Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 32.81B | 32.70B | 31.49B | 29.89B | 29.05B |
Gross Profit | 2.22B | 2.34B | 2.32B | 2.21B | 2.04B |
EBITDA | 2.19B | 1.99B | 1.84B | 2.40B | 1.44B |
Net Income | 242.00M | 137.00M | 207.00M | 677.00M | -208.00M |
Balance Sheet | |||||
Total Assets | 24.65B | 25.06B | 26.39B | 27.15B | 25.47B |
Cash, Cash Equivalents and Short-Term Investments | 3.39B | 2.00B | 1.81B | 1.02B | 1.67B |
Total Debt | 6.61B | 6.55B | 7.14B | 7.38B | 6.94B |
Total Liabilities | 18.00B | 18.19B | 19.13B | 18.73B | 18.77B |
Stockholders Equity | 6.65B | 6.87B | 7.25B | 8.42B | 6.70B |
Cash Flow | |||||
Free Cash Flow | 505.00M | 548.00M | 1.66B | 202.00M | 1.50B |
Operating Cash Flow | 1.36B | 1.97B | 2.39B | 896.00M | 2.10B |
Investing Cash Flow | -787.00M | -1.01B | -725.00M | -651.00M | -575.00M |
Financing Cash Flow | -1.12B | -282.00M | -960.00M | -1.02B | -1.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $8.70B | 20.11 | 6.29% | 6.50% | 2.28% | 157.72% | |
73 Outperform | $46.11B | 18.96 | 24.06% | 1.82% | -2.11% | 25.03% | |
72 Outperform | $15.63B | 35.73 | 35.74% | ― | 15.51% | 53.77% | |
71 Outperform | $12.50B | 13.50 | 31.26% | 2.69% | 1.46% | -26.54% | |
69 Neutral | $1.99B | 18.57 | 7.54% | 1.84% | 1.76% | 6.01% | |
65 Neutral | $26.88B | 15.20 | -4.27% | 3.19% | 1.02% | 1.89% | |
58 Neutral | $1.26B | 77.70 | 1.43% | ― | 10.37% | -73.84% |